The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

ASH 2019 Update on Myeloproliferative Neoplasms: CPI-0610 (BET Inhibitor) Mono or + Ruxolitinib Demonstrated Antitumor Activity in R/R/I Disease

21 views
February 13, 2020
Comments 0
Login to view comments. Click here to Login